Chief Financial Officer
Vancouver, British Columbia, Canada
Angiotech was a global specialty pharmaceutical and medical device company that discovered, developed, manufactured and marketed innovative technologies and medical products. The Company had manufacturing operations in the United States, Europe, Puerto Rico and Mexico and had peak annual revenues of $245 million and 1,500 employees. At Angiotech, I oversaw the global finance, information technology and property management functions, including accounting, public and internal reporting, corporate tax, business planning, Sarbanes Oxley compliance, treasury, risk management, product and project costing and commercial decision support. Reporting to the CEO, I led a global team of over 60 professional and support staff.